4-Iodo-1-tritylimidazole → HCID 59749576, Verbindung
Reaktionsgleichung
I[C:2]1[N:3]=[CH:4][N:5]([C:7]([C:20]2[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=2)([C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=2)[C:8]2[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=2)[CH:6]=1.C([Mg]Br)C.CON(C)[C:33]([C:35]1[C:40]2=[N:41][S:42][N:43]=[C:39]2[CH:38]=[CH:37][CH:36]=1)=[O:34]>ClCCl>[N:43]1[S:42][N:41]=[C:40]2[C:35]([C:33]([C:2]3[N:3]=[CH:4][N:5]([C:7]([C:8]4[CH:9]=[CH:10][CH:11]=[CH:12][CH:13]=4)([C:20]4[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=4)[C:14]4[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=4)[CH:6]=3)=[O:34])=[CH:36][CH:37]=[CH:38][C:39]=12Komponenten
5
Edukt 3
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
A mixture of 4-iodo-1-tritylimidazole (commercially available from Synchem) (6.3 g, 14.4 mmol) in dichloromethane (100 mL) at rt was treated with ethyl magnesium bromide (4.8 mL, 14.4 mmol, 3M in THF) and allowed to react for 1 h. A solution of benzo[1,2,5]thiadiazole-4-carboxylic acid methoxy-methyl-amide (Intermediate L2) (2.0 g, 9.0 mmol) in dichloromethane (50 mL) was added via syringe at rt and stirred for 40 m. The residue was isolated in a typical aqueous workup and purified by chromatography on silica gel with 30% EtOAc:hexane to give benzo[1,2,5]thiadiazol-4-yl-(1-trityl-1H-imidazol-4-yl)-methanone (Intermediate L3), 1 g (25%).
Aufarbeitung
- customto react for 1 h
- customThe residue was isolated in a typical aqueous workup
- custompurified by chromatography on silica gel with 30% EtOAc
Quellen und Nachweise
- ORD-Eintrag
- ord-b60f56f9b1e2412daf19f48660eda6e0
- Quelldatensatz
- uspto-grants-2008_07
- Patentnummer
- US07396849B2
Notizen zur Reaktion
Wird geladen…